{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:38:57Z","timestamp":1768448337976,"version":"3.49.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gofs.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T12:38:32Z","timestamp":1541507912000},"page":"845-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Contraception hormonale en pratique hors dispositifs intra-ut\u00e9rins. RPC Contraception CNGOF"],"prefix":"10.1016","volume":"46","author":[{"given":"G.","family":"Robin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Plouvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-S.","family":"Delesalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-L.","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0015-0282(01)01689-2","article-title":"Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition","volume":"75","author":"Mulders","year":"2001","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0010","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.contraception.2012.12.001","article-title":"Contraceptive vaginal ring effectiveness is maintained during 6\u00a0weeks of use: a prospective study of normal BMI and obese women","volume":"87","author":"Dragoman","year":"2013","journal-title":"Contraception"},{"issue":"5\u00a0Pt 1","key":"10.1016\/j.gofs.2018.10.003_bib0015","first-page":"799","article-title":"Efficacy and safety of a transdermal contraceptive system","volume":"98","author":"Smallwood","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0020","first-page":"CD003552","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gofs.2018.10.003_bib0025","article-title":"Contraception hormonale et risque vasculaire. RPC Contraception CNGOF","volume":"46","author":"Plu-Bureau","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0030","first-page":"267","article-title":"Medical treatment for the management of painful endometriosis without infertility: CNGOF-HAS Endometriosis Guidelines","volume":"46","author":"Sauvan","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.003_bib0035","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception","author":"Edelman","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0040","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/AOG.0b013e31820afc46","article-title":"Continuation of prescribed compared with over-the-counter oral contraceptives","volume":"117","author":"Potter","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.003_bib0045","series-title":"Crit\u00e8res de recevabilit\u00e9 m\u00e9dicale pour l\u2019adoption et l\u2019utilisation continue de m\u00e9thodes contraceptives","author":"OMS","year":"2015"},{"issue":"Suppl 2","key":"10.1016\/j.gofs.2018.10.003_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/humrep\/11.suppl_2.20","article-title":"Progestogen-only pills and bleeding disturbances","volume":"11","author":"Kovacs","year":"1996","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0055","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/14.4.982","article-title":"A comparison of the inhibition of ovulation achieved by desogestrel 75\u00a0micrograms and levonorgestrel 30\u00a0micrograms daily","volume":"14","author":"Rice","year":"1999","journal-title":"Hum Reprod"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.003_bib0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.gyobfe.2011.08.031","article-title":"Forgetting hormonal contraceptive methods: expert opinion about their daily management in clinical routine practice","volume":"39","author":"Jamin","year":"2011","journal-title":"Gynecol Obstet Fertil"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.003_bib0065","first-page":"CD007541","article-title":"Progestin-only pills for contraception","author":"Grimes","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"10.1016\/j.gofs.2018.10.003_bib0070","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.beem.2012.09.001","article-title":"Obesity and oral contraceptives: a clinician's guide","volume":"27","author":"Shaw","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.contraception.2004.10.005","article-title":"Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia","volume":"71","author":"Harrison-Woolrych","year":"2005","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.05.002","article-title":"Pharmacokinetics of the etonogestrel contraceptive implant in obese women","volume":"207","author":"Mornar","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.contraception.2015.11.005","article-title":"Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1\u00a0year","volume":"93","author":"Morrell","year":"2016","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women","volume":"120","author":"Xu","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.003_bib0100","first-page":"CD008452","article-title":"Hormonal contraceptives for contraception in overweight or obese women","author":"Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.003_bib0105","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/humrep\/dew222","article-title":"Extended use up to 5\u00a0years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant","volume":"31","author":"Ali","year":"2016","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0110","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/AOG.0000000000000690","article-title":"Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration","volume":"125","author":"McNicholas","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0010-7824(03)00136-7","article-title":"Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety","volume":"68","author":"Westhoff","year":"2003","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.003_bib0120","first-page":"CD009849","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","author":"Lopez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.003_bib0125","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1089\/jwh.2014.5077","article-title":"Prevalence of low bone mass and osteoporosis in long-term users of the injectable contraceptive depot medroxyprogesterone acetate","volume":"24","author":"Modesto","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00198-016-3714-4","article-title":"The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK","volume":"28","author":"Kyvernitakis","year":"2017","journal-title":"Osteoporos Int"},{"issue":"5\u00a0Suppl","key":"10.1016\/j.gofs.2018.10.003_bib0135","first-page":"381","article-title":"Pharmacokinetics of depot medroxyprogesterone acetate contraception","volume":"41","author":"Mishell","year":"1996","journal-title":"J Reprod Med"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2010.01.021","article-title":"Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously","volume":"81","author":"Segall-Gutierrez","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.gofs.2018.10.003_bib0150","first-page":"CD006260","article-title":"Immediate start of hormonal contraceptives for contraception","volume":"12","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 8","key":"10.1016\/j.gofs.2018.10.003_bib0155","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1016\/S0368-2315(08)74776-8","article-title":"Treatment of metrorrhagia, breakthrough bleeding and spotting under contraceptives","volume":"37","author":"Gompel","year":"2008","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"5\u00a0Pt 2","key":"10.1016\/j.gofs.2018.10.003_bib0160","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0002-9378(94)05013-1","article-title":"Menstrual impact of contraception","volume":"170","author":"Stubblefield","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.003_bib0165","first-page":"CD003989","article-title":"20\u00a0microg versus>20\u00a0microg estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0028-2243(90)90079-G","article-title":"A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30","volume":"34","author":"Loudon","year":"1990","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0175","first-page":"CD004861","article-title":"Types of progestogens in combined oral contraception: effectiveness and side-effects","author":"Lawrie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.003_bib0180","first-page":"CD003553","article-title":"Triphasic versus monophasic oral contraceptives for contraception","author":"Van Vliet","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0185","first-page":"CD002032","article-title":"Biphasic versus monophasic oral contraceptives for contraception","author":"Van Vliet","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.003_bib0190","first-page":"CD009038","article-title":"Quadriphasic versus monophasic oral contraceptives for contraception","author":"Van Vliet","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0195","first-page":"CD003283","article-title":"Biphasic versus triphasic oral contraceptives for contraception","author":"Van Vliet","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13625187.2017.1287351","article-title":"Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis","volume":"22","author":"Lopez-Picado","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6\u00a0Suppl. 1","key":"10.1016\/j.gofs.2018.10.003_bib0205","first-page":"S1","article-title":"Progestin-only oral contraception: a comprehensive review","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0210","first-page":"CD001326","article-title":"Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy","author":"Power","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0215","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.contraception.2010.09.012","article-title":"Bleeding related to etonogestrel subdermal implant in a US population","volume":"83","author":"Casey","year":"2011","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","article-title":"Unscheduled vaginal bleeding with progestin-only contraceptive use","volume":"216","author":"Zigler","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.003_bib0225","first-page":"CD003449","article-title":"Treatment of vaginal bleeding irregularities induced by progestin only contraceptives","author":"Abdel-Aleem","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.003_bib0230","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0235","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/humupd\/dmw016","article-title":"Hormonal contraceptives: pharmacology tailored to women's health","volume":"22","author":"De Leo","year":"2016","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0240","first-page":"670","article-title":"Hormonal contraceptives and acne: a retrospective analysis of 2147\u00a0Patients","volume":"15","author":"Lortscher","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0245","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaad.2012.11.018","article-title":"Contraception and the dermatologist","volume":"68","author":"Tyler","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.003_bib0250","first-page":"1499","article-title":"Managing adverse effects of hormonal contraceptives","volume":"82","author":"Grossman Barr","year":"2010","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13625187.2012.728643","article-title":"The influence of combined oral contraceptives on female sexual desire: a systematic review","volume":"18","author":"Pastor","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.003_bib0260","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1743-6109.2012.02848.x","article-title":"The effects of hormonal contraceptives on female sexuality: a review","volume":"9","author":"Burrows","year":"2012","journal-title":"J Sex Med"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.contraception.2010.02.016","article-title":"Effects of two combined hormonal contraceptives with the same composition and different doses on female sexual function and plasma androgen levels","volume":"82","author":"Strufaldi","year":"2010","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.contraception.2003.11.001","article-title":"Sexual behavior of women taking low-dose oral contraceptive containing 15\u00a0microg ethinylestradiol\/60\u00a0microg gestodene","volume":"69","author":"Caruso","year":"2004","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2006.03.022","article-title":"Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives","volume":"74","author":"Sabatini","year":"2006","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13625180701712406","article-title":"Evaluation of the quality of life and sexual functioning of women using a 30-microg ethinyloestradiol and 3-mg drospirenone combined oral contraceptive","volume":"13","author":"Skrzypulec","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0285","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/13625187.2016.1217324","article-title":"The effect of a drospirenone-containing combined oral contraceptive on female sexual function: a prospective randomised study","volume":"21","author":"Ciaplinskiene","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0290","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.contraception.2010.01.011","article-title":"Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02mg ethinylestradiol and 2mg chlormadinone acetate administered in a 24\/4-day regimen","volume":"81","author":"Brucker","year":"2010","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.003_bib0295","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/j.1743-6109.2009.01529.x","article-title":"Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate","volume":"6","author":"Caruso","year":"2009","journal-title":"J Sex Med"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0300","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/11586720-000000000-00000","article-title":"Extended cycles with the combined oral contraceptive chlormadinone acetate 2mg\/ethinylestradiol 0.03mg: pooled analysis of data from three large-scale, non-interventional, observational studies","volume":"31","author":"Goretzlehner","year":"2011","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0305","first-page":"47","article-title":"Comparing the effects of the second-and third-generation oral contraceptives on sexual functioning","volume":"20","author":"Shahnazi","year":"2015","journal-title":"Iran J Nurs Midwifery Res"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.003_bib0310","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1111\/j.1743-6109.2011.02409.x","article-title":"Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V\/DNG) oral contraceptive on the quality of sexual life","volume":"8","author":"Caruso","year":"2011","journal-title":"J Sex Med"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.003_bib0315","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3109\/09513590.2014.975688","article-title":"Effects of estradiol valerate and dienogest on quality of life and sexual function according to age","volume":"30","author":"Di Carlo","year":"2014","journal-title":"Gynecol Endocrinol"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.003_bib0320","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/jsm.12310","article-title":"Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction","volume":"10","author":"Davis","year":"2013","journal-title":"J Sex Med"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.003_bib0325","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1089\/jwh.2016.5801","article-title":"Improvement of low sexual desire due to antiandrogenic combined oral contraceptives after switching to an oral contraceptive containing 17\u00a0beta-Estradiol","volume":"26","author":"Caruso","year":"2017","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/13625187.2014.914488","article-title":"Quality of sexual life of women using the contraceptive vaginal ring in extended cycles: preliminary report","volume":"19","author":"Caruso","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.003_bib0335","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1080\/09513590.2017.1306850","article-title":"Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study","volume":"33","author":"Morotti","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0340","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/TCRM.S1964","article-title":"Review of the combined contraceptive vaginal ring, NuvaRing","volume":"4","author":"Roumen","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.gofs.2018.10.003_bib0345","first-page":"86","article-title":"A new long-term reversible contraception method: sexual and metabolic impact","volume":"4","author":"Visconti","year":"2012","journal-title":"Transl Med UniSa"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0350","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/09513590.2013.848851","article-title":"Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study","volume":"30","author":"Di Carlo","year":"2014","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0355","first-page":"CD003987","article-title":"Combination contraceptives: effects on weight","author":"Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.10.876","article-title":"Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate","volume":"208","author":"Nault","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0365","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.contraception.2013.03.004","article-title":"Weight change at 12\u00a0months in users of three progestin-only contraceptive methods","volume":"88","author":"Vickery","year":"2013","journal-title":"Contraception"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.003_bib0370","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The international classification of headache disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society","year":"2013","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0375","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1468-2982.2000.00038.x","article-title":"Evolution and treatment of migraine with oral contraceptives","volume":"20","author":"Massiou","year":"2000","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0380","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.contraception.2009.09.006","article-title":"Epidemiological and clinical aspects of migraine in users of combined oral contraceptives","volume":"81","author":"Machado","year":"2010","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0385","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1212\/01.wnl.0000196481.57994.09","article-title":"Oral contraceptives and increased headache prevalence: the Head-HUNT Study","volume":"66","author":"Aegidius","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0390","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/head.12035","article-title":"Contraception and headache","volume":"53","author":"MacGregor","year":"2013","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0395","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.contraception.2013.02.001","article-title":"Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V\/DNG) in women with menstrually-related migraine (MRM)","volume":"88","author":"Nappi","year":"2013","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.003_bib0400","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1212\/01.wnl.0000233888.18228.19","article-title":"Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen","volume":"67","author":"MacGregor","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0405","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","article-title":"Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval","volume":"47","author":"Sulak","year":"2007","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0410","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2009.10.010","article-title":"Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study","volume":"81","author":"Machado","year":"2010","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0415","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.fertnstert.2004.12.048","article-title":"Suppression of estrogen-withdrawal headache with extended transdermal contraception","volume":"83","author":"LaGuardia","year":"2005","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.003_bib0420","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1526-4610.2012.02211.x","article-title":"The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series","volume":"52","author":"Calhoun","year":"2012","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.003_bib0425","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.SMJ.0000129924.15619.D9","article-title":"A novel specific prophylaxis for menstrual-associated migraine","volume":"97","author":"Calhoun","year":"2004","journal-title":"South Med J"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0430","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1783\/147118902101195974","article-title":"Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural \u0153strogen supplements","volume":"28","author":"Macgregor","year":"2002","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.003_bib0435","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1093\/humrep\/dei260","article-title":"Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval","volume":"20","author":"Nappi","year":"2005","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0440","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.fertnstert.2011.07.1089","article-title":"Combined oral contraceptives in women with menstrual migraine without aura","volume":"96","author":"De Leo","year":"2011","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0445","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/13625187.2013.814769","article-title":"Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine","volume":"18","author":"Merki-Feld","year":"2013","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.gofs.2018.10.003_bib0450","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1129-2377-14-66","article-title":"Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?","volume":"14","author":"Nappi","year":"2013","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0455","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2010.07.024","article-title":"Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study","volume":"83","author":"Nappi","year":"2011","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0460","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0333102412473373","article-title":"Headache frequency and intensity in female migraineurs using desogestrel-only contraception: a retrospective pilot diary study","volume":"33","author":"Merki-Feld","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.gofs.2018.10.003_bib0465","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s10194-015-0522-8","article-title":"Positive effects of the progestin desogestrel 75\u03bcg on migraine frequency and use of acute medication are sustained over a treatment period of 180\u00a0days","volume":"16","author":"Merki-Feld","year":"2015","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.003_bib0470","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gyobfe.2015.01.006","article-title":"Migraine and contraception","volume":"43","author":"Cappy","year":"2015","journal-title":"Gynecol Obstet Fertil"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0475","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neurol.2012.07.022","article-title":"Guidelines for the diagnosis and management of migraine in adults and children","volume":"169","author":"Lanteri-Minet","year":"2013","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0480","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/13625187.2016.1217327","article-title":"Combined hormonal contraception and its effects on mood: a critical review","volume":"21","author":"Schaffir","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.003_bib0485","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/aje\/kwt188","article-title":"Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States","volume":"178","author":"Keyes","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.003_bib0490","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/humrep\/der269","article-title":"Hormonal contraception and mental health: results of a population-based study","volume":"26","author":"Toffol","year":"2011","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0495","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2012.02.014","article-title":"Further evidence for lack of negative associations between hormonal contraception and mental health","volume":"86","author":"Toffol","year":"2012","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0500","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.contraception.2006.08.002","article-title":"Is there an association between the use of oral contraception and depressive symptoms in young Australian women?","volume":"75","author":"Duke","year":"2007","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0505","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jad.2012.03.030","article-title":"The use of hormonal contraceptive agents and mood disorders in women","volume":"140","author":"Svendal","year":"2012","journal-title":"J Affect Disord"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.003_bib0510","first-page":"990","article-title":"Depression associated with combined oral contraceptives\u00a0\u2013\u00a0a pilot study","volume":"34","author":"Kulkarni","year":"2005","journal-title":"Aust Fam Physician"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0515","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0010-7824(02)00314-1","article-title":"Attitudes and experiences with levonorgestrel 100\u00a0microg\/ethinyl estradiol 20\u00a0microg among women during a 3-month trial","volume":"65","author":"Wimberly","year":"2002","journal-title":"Contraception"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.003_bib0520","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1471-0528.1993.tb14309.x","article-title":"Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150\u00a0micrograms desogestrel and either 30\u00a0micrograms or 20\u00a0micrograms ethinyl oestradiol","volume":"100","author":"Akerlund","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0525","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2007.04.002","article-title":"The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35\u00a0or 25\u00a0microg of ethinyl estradiol","volume":"76","author":"Greco","year":"2007","journal-title":"Contraception"},{"issue":"4\u20135","key":"10.1016\/j.gofs.2018.10.003_bib0530","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0022-3999(88)90025-6","article-title":"Mood, sexuality, oral contraceptives and the menstrual cycle","volume":"32","author":"Warner","year":"1988","journal-title":"J Psychosom Res"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0535","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0022-3999(93)90086-U","article-title":"The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms","volume":"37","author":"Bancroft","year":"1993","journal-title":"J Psychosom Res"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0540","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2006.05.012","article-title":"Oral contraceptives and premenstrual symptoms: comparison of a 21\/7\u00a0and extended regimen","volume":"195","author":"Coffee","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2018.10.003_bib0545","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psyneuen.2016.11.033","article-title":"Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial","volume":"76","author":"Lundin","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0550","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception","volume":"121","author":"Urdl","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0555","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpag.2011.02.001","article-title":"Adolescents\u2019 experiences using the contraceptive patch versus pills","volume":"24","author":"Sucato","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0560","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0010-7824(92)90098-E","article-title":"Use of a monophasic, low-dose oral contraceptive in relation to mental functioning","volume":"46","author":"Deijen","year":"1992","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0565","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/11535450-000000000-00000","article-title":"Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study","volume":"30","author":"Kelly","year":"2010","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.003_bib0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2004.07.010","article-title":"A comparative study of monophasic oral contraceptives containing either drospirenone 3mg or levonorgestrel 150\u00a0microg on premenstrual symptoms","volume":"71","author":"Sangthawan","year":"2005","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0575","first-page":"79","article-title":"Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life","volume":"48","author":"Borenstein","year":"2003","journal-title":"J Reprod Med"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.003_bib0580","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.psyneuen.2012.11.006","article-title":"Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill\u00a0\u2013\u00a0a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive","volume":"38","author":"Gingnell","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0585","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.psyneuen.2008.01.007","article-title":"Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls","volume":"33","author":"Borgstrom","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.003_bib0590","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamapsychiatry.2016.2387","article-title":"Association of hormonal contraception with depression","volume":"73","author":"Skovlund","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0595","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0010-7824(98)00024-9","article-title":"Depressive symptoms and depo-provera","volume":"57","author":"Westhoff","year":"1998","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0600","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2018.01.010","article-title":"The relationship between progestin hormonal contraception and depression: a systematic review","volume":"97","author":"Worly","year":"2018","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0605","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-7824(97)00140-6","article-title":"Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation","volume":"56","author":"Paul","year":"1997","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0610","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0029-7844(96)00194-9","article-title":"Experiences of injectable contraceptive users in an urban setting","volume":"88","author":"Sangi-Haghpeykar","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0615","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0010-7824(98)00022-5","article-title":"Depressive symptoms and Norplant contraceptive implants","volume":"57","author":"Westhoff","year":"1998","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0620","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0010-7824(95)00100-O","article-title":"Depression in users of depo-medroxyprogesterone acetate","volume":"51","author":"Westhoff","year":"1995","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.003_bib0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.04.048","article-title":"Physiologic and psychologic symptoms associated with use of injectable contraception and 20\u00a0microg oral contraceptive pills","volume":"199","author":"Berenson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0630","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0010-7824(00)00122-0","article-title":"Depressive symptoms in users and non-users of depot medroxyprogesterone acetate","volume":"61","author":"Civic","year":"2000","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.003_bib0635","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0010-7824(95)00226-X","article-title":"The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods","volume":"52","author":"Graham","year":"1995","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.003_bib0640","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1083-3188(01)00074-2","article-title":"Mood changes in adolescents using depot-medroxyprogesterone acetate for contraception: a prospective study","volume":"14","author":"Gupta","year":"2001","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0645","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1542\/peds.94.5.687","article-title":"A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception","volume":"94","author":"Cromer","year":"1994","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.003_bib0650","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1054-139X(95)00094-9","article-title":"Depo-Provera in adolescents: effects of early second injection or prior oral contraception","volume":"16","author":"Harel","year":"1995","journal-title":"J Adolesc Health"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.003_bib0655","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.psyneuen.2007.05.013","article-title":"Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression","volume":"32","author":"Young","year":"2007","journal-title":"Psychoneuroendocrinology"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T11:23:13Z","timestamp":1662376993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918302587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":131,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2468718918302587"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.003","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contraception hormonale en pratique hors dispositifs intra-ut\u00e9rins. RPC Contraception CNGOF","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}